Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in AIDS

Retrieve available abstracts of 403 articles:
HTML format
Text format



Single Articles


    June 2017
  1. DALLA PRIA A, Merchant S, Bower M
    Oncological challenges for an ageing population living with HIV.
    AIDS. 2017;31 Suppl 2:S185-S189.
    PubMed     Text format     Abstract available


  2. SMITH JM, Flexner C
    The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development.
    AIDS. 2017;31 Suppl 2:S173-S184.
    PubMed     Text format     Abstract available


  3. NIGHTINGALE S, Winston A
    Measuring and managing cognitive impairment in HIV.
    AIDS. 2017;31 Suppl 2:S165-S172.
    PubMed     Text format     Abstract available


  4. BOCCARA F
    Cardiovascular health in an aging HIV population.
    AIDS. 2017;31 Suppl 2:S157-S163.
    PubMed     Text format     Abstract available


  5. GUARALDI G, Lonardo A, Maia L, Palella FJ Jr, et al
    Metabolic concerns in aging HIV-infected persons: from serum lipid phenotype to fatty liver.
    AIDS. 2017;31 Suppl 2:S147-S156.
    PubMed     Text format     Abstract available


  6. HAWKINS KL, Brown TT, Margolick JB, Erlandson KM, et al
    Geriatric syndromes: new frontiers in HIV and sarcopenia.
    AIDS. 2017;31 Suppl 2:S137-S146.
    PubMed     Text format     Abstract available


  7. GUARALDI G, Palella FJ Jr
    Clinical implications of aging with HIV infection: perspectives and the future medical care agenda.
    AIDS. 2017;31 Suppl 2:S129-S135.
    PubMed     Text format     Abstract available


  8. SABIN CA, Reiss P
    Epidemiology of ageing with HIV: what can we learn from cohorts?
    AIDS. 2017;31 Suppl 2:S121-S128.
    PubMed     Text format     Abstract available


  9. LAGATHU C, Cossarizza A, Bereziat V, Nasi M, et al
    Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers.
    AIDS. 2017;31 Suppl 2:S105-S119.
    PubMed     Text format     Abstract available


  10. TODESCO E, Demeret S, Calin R, Roque-Afonso AM, et al
    Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin.
    AIDS. 2017;31:1346-1348.
    PubMed     Text format    


  11. MCMAHON JH, Chang J, Tennakoon S, Dantanarayana A, et al
    Post-treatment control in an adult with perinatally acquired HIV following cessation of antiretroviral therapy.
    AIDS. 2017;31:1344-1346.
    PubMed     Text format    


  12. ESSER S, Streeck H
    Preexposure prophylaxis failure with tenofovir disoproxil.
    AIDS. 2017;31:1344.
    PubMed     Text format    


  13. FOX J, Collins S
    HIV prevention: response to pre-exposure prophylaxis failure with tenofovir disoproxil.
    AIDS. 2017;31:1343.
    PubMed     Text format    


  14. MARSHALL BDL, Tate JP, McGinnis KA, Bryant KJ, et al
    Long-term alcohol use patterns and HIV disease severity.
    AIDS. 2017;31:1313-1321.
    PubMed     Text format     Abstract available


  15. RYOM L, Mocroft A, Kirk O, Reiss P, et al
    Predictors of estimated glomerular filtration rate progression, stabilization or improvement after chronic renal impairment in HIV-positive individuals.
    AIDS. 2017;31:1261-1270.
    PubMed     Text format     Abstract available


  16. GRIESBECK M, Valantin MA, Lacombe K, Samri-Hassimi A, et al
    Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals.
    AIDS. 2017;31:1223-1234.
    PubMed     Text format     Abstract available


  17. LECCA L, Galea J, Contreras CC, Millones AK, et al
    Challenges in tuberculosis/HIV management in a country with a concentrated HIV epidemic.
    AIDS. 2017;31:1207-1209.
    PubMed     Text format    


    May 2017
  18. TOBIN SC
    Recent Progress in Anti-HIV Broadly Neutralizing Antibody Research.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001544.
    PubMed     Text format    


  19. O'MALLEY TK, Burdo TH, Robinson JA, Fitch KV, et al
    Acute hyperinsulinemia effects on systemic markers of immune activation in HIV.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001545.
    PubMed     Text format     Abstract available


  20. YOUN B, Shireman TI, Lee Y, Galarraga O, et al
    Ten-year trends in anti-retroviral therapy persistence among US medicaid beneficiaries, 2001-2010.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001541.
    PubMed     Text format     Abstract available


  21. RASMUSSEN TA, McMahon J, Chang JJ, Symons J, et al
    Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001540.
    PubMed     Text format     Abstract available


  22. BLASER N, Bertisch B, Kouyos RD, Calmy A, et al
    Impact of screening and ART on anal cancer incidence in HIV-positive men who have sex with men: mathematical modeling study.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001546.
    PubMed     Text format     Abstract available


  23. ALSAN M, Beshears J, Armstrong WS, Choi JJ, et al
    A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001543.
    PubMed     Text format     Abstract available


  24. OMORI R, Abu-Raddad LJ
    Sexual network drivers of HIV and herpes simplex virus type 2 (HSV-2) transmission: a comparative mathematical modeling analysis.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001542.
    PubMed     Text format     Abstract available


  25. GATHOGO EN, Shah S, Post FA
    Kidney transplant outcomes in HIV serodiscordant recipient pairs.
    AIDS. 2017;31:1199-1201.
    PubMed     Text format    


  26. ORIKIIRIZA J, Nakawesi J, Kikaire B, Turitwenka D, et al
    Unmet needs persist in pediatric HIV programs: lessons from selected case studies in Uganda.
    AIDS. 2017;31:1196-1199.
    PubMed     Text format    


  27. AL TABAA O, Audren V, Hayton E, Pertuiset E, et al
    Right hip and bilateral shoulder capsulitis in an HIV-infected individual treated with elvitegravir and cobicistat.
    AIDS. 2017;31:1195-1196.
    PubMed     Text format    


  28. DUTTA A, Uno H, Holman A, Lorenz DR, et al
    Long-term nitrite inhalant exposure and cancer risk in MSM.
    AIDS. 2017;31:1169-1180.
    PubMed     Text format     Abstract available


  29. MONTGOMERY ET, van der Straten A, Chitukuta M, Reddy K, et al
    Acceptability and use of a dapivirine vaginal ring in a phase III trial.
    AIDS. 2017;31:1159-1167.
    PubMed     Text format     Abstract available


  30. MEIJIDE H, Pertega S, Rodriguez-Osorio I, Castro-Iglesias A, et al
    Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfected.
    AIDS. 2017;31:1099-1107.
    PubMed     Text format     Abstract available


  31. VANPOUILLE C, Bernatchez JA, Lisco A, Arakelyan A, et al
    A common anti-CMV drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo.
    AIDS. 2017 May 5. doi: 10.1097/QAD.0000000000001532.
    PubMed     Text format     Abstract available


  32. TOBIN SC
    WHO provides additional guidance on HIV self-testing and partner notification.
    AIDS. 2017 May 5. doi: 10.1097/QAD.0000000000001537.
    PubMed     Text format    


  33. MORENO M, Caballero E, Mateus RM, Samba F, et al
    HIV drug resistance in Africa: an emerging problem that deserves urgent attention.
    AIDS. 2017 May 5. doi: 10.1097/QAD.0000000000001536.
    PubMed     Text format    


  34. CABY F
    CD4/CD8 ratio restoration in long-term treated HIV-1-infected individuals: Incidence and determinants.
    AIDS. 2017 May 5. doi: 10.1097/QAD.0000000000001533.
    PubMed     Text format     Abstract available


  35. KENNEDY CE, Yeh PT, Pandey S, Betran AP, et al
    Elective cesarean section for women living with HIV: a systematic review of risks and benefits.
    AIDS. 2017 May 5. doi: 10.1097/QAD.0000000000001535.
    PubMed     Text format     Abstract available


  36. SHANAUBE K, Schaap A, Floyd S, Phiri M, et al
    What works-reaching universal hiv testing: lessons from HPTN 071 (PopART) trial in Zambia.
    AIDS. 2017 May 3. doi: 10.1097/QAD.0000000000001514.
    PubMed     Text format     Abstract available


  37. COBAN H, Robertson K, Smurzynski M, Krishnan S, et al
    Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV+ individuals on their first suppressive regimen.
    AIDS. 2017 May 3. doi: 10.1097/QAD.0000000000001523.
    PubMed     Text format     Abstract available


  38. CREPAZ N, Dong B, Chen M, Hall I, et al
    Examination of HIV infection through heterosexual contact with partners who are known to be HIV infected in the United States, 2010-2015.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001526.
    PubMed     Text format     Abstract available


  39. GUNST JD, Tolstrup M, Sogaard OS
    Beyond antiretroviral therapy: Early interventions to control HIV-1 infection.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001524.
    PubMed     Text format    


  40. KIM CJ, Rousseau R, Huibner S, Kovacs C, et al
    Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers: a randomized controlled trial.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001515.
    PubMed     Text format     Abstract available


  41. TRIPLETTE M, Sigel KM, Morris A, Shahrir S, et al
    Emphysema and soluble CD14 are associated with pulmonary nodules in HIV-infected patients: Implications for lung cancer screening.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001529.
    PubMed     Text format     Abstract available


  42. LAL L, Audsley J, Murphy D, Fairley CK, et al
    Medication adherence, condom use and sexually transmitted infections in Australian PrEP users: interim results from the Victorian PrEP Demonstration Project.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001519.
    PubMed     Text format     Abstract available


  43. LONG LC, Maskew M, Brennan AT, Mongwenyana C, et al
    Initiating antiretroviral therapy for HIV at a patient's first clinic visit: A cost-effectiveness analysis of the RapIT randomized controlled trial.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001528.
    PubMed     Text format     Abstract available


  44. HOORNENBORG E, Achterbergh RCA, Schim Van Der Loeff MF, Davidovich U, et al
    Men who have sex with men starting pre-exposure prophylaxis (PrEP) are at risk of HCV infection: evidence from the Amsterdam PrEP study.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001522.
    PubMed     Text format     Abstract available


  45. ONOYA D, Sineke T, Brennan A, Long L, et al
    Timing of pregnancy, postpartum risk of virologic failure and loss to follow-up among HIV-positive women.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001517.
    PubMed     Text format     Abstract available


  46. ANDERSON DJ, Politch JA, Zeitlin L, Hiatt A, et al
    Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV.
    AIDS. 2017 May 1. doi: 10.1097/QAD.0000000000001521.
    PubMed     Text format     Abstract available


    April 2017
  47. WINSTON A, Julie F, Fidler S
    HIV cure strategies: response to ignore the central nervous system at your patients' peril.
    AIDS. 2017;31:1051-1052.
    PubMed     Text format    


  48. LE GARFF G, Samri A, Lambert-Niclot S, Even S, et al
    Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab.
    AIDS. 2017;31:1048-1051.
    PubMed     Text format    


  49. MCLEAN FE, Gathogo E, Goodall D, Jones R, et al
    Alemtuzumab induction therapy in HIV-positive renal transplant recipients.
    AIDS. 2017;31:1047-1048.
    PubMed     Text format    


  50. FRANCESCHI S, Clifford GM
    Cervical screening: toward an equal risk/equal management approach, irrespective of HIV status.
    AIDS. 2017;31:1045-1046.
    PubMed     Text format    


  51. WAMBURA M, Mahler H, Grund JM, Larke N, et al
    Increasing voluntary medical male circumcision uptake among adult men in Tanzania.
    AIDS. 2017;31:1025-1034.
    PubMed     Text format     Abstract available


  52. BREGIGEON S, Galinier A, Zaegel-Faucher O, Cano CE, et al
    Frailty in HIV infected people: a new risk factor for bone mineral density loss.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001507.
    PubMed     Text format     Abstract available


  53. SCHAEFER R, Gregson S, Eaton JW, Mugurungi O, et al
    Age-disparate relationships and HIV incidence in adolescent girls and young women: evidence from a general-population cohort in Zimbabwe.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001506.
    PubMed     Text format     Abstract available


  54. GIBELLINI L, Pecorini S, de Biasi S, Bianchini E, et al
    HIV-DNA content in different CD4+ T cell subsets correlates with CD4: CD8 ratio or length of efficient treatment.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001510.
    PubMed     Text format     Abstract available


  55. LANGEBEEK N, Kooij KW, Wit FW, Stolte IG, et al
    Impact of co-morbidity and aging on health-related quality of life in HIV-positive and HIV-negative individuals.
    AIDS. 2017 Apr 19. doi: 10.1097/QAD.0000000000001511.
    PubMed     Text format     Abstract available


  56. MAURICE JB, Patel A, Scott AJ, Patel K, et al
    Prevalence and risk factors of non-alcoholic fatty liver disease in HIV-monoinfection: a systematic review and meta-analysis.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001504.
    PubMed     Text format     Abstract available


  57. INZAULE SC, Hamers RL, Mukui I, Were K, et al
    Emergence of untreatable, multidrug-resistant HIV-1 in patients failing second-line therapy in Kenya.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001500.
    PubMed     Text format     Abstract available


  58. PUTCHAROEN O, Wattanachanya L, Sophonphan J, Siwamogsatham S, et al
    New-onset diabetes in hiv treated adults from thailand: predictors, long-term renal and cardiovascular outcomes.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001496.
    PubMed     Text format     Abstract available


  59. SWEENEY P, Gray SC, Purcell DW, Sewell J, et al
    Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001501.
    PubMed     Text format     Abstract available


  60. UBAIDA-MOHIEN C, Lamberty B, Dickens AM, Mielke MM, et al
    Informatic interrogation of CSF proteomic profiles from HIV-infected subjects implicates acute phase and complement systems in shifting cognitive status.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001503.
    PubMed     Text format     Abstract available


  61. MCGRATH N, Grapsa E
    Does ART change partnership dynamics and HIV risk behaviours among PLWH? A cohort study in KwaZulu-Natal, South Africa.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001502.
    PubMed     Text format     Abstract available


  62. FORHAN SE, Modi S, Houston JC, Broyles LN, et al
    Moving towards test and start: learning from the experience of universal ART programs for HIV-infected pregnant/breastfeeding women.
    AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001498.
    PubMed     Text format     Abstract available


  63. LEPIK KJ, Harrigan PR, Yip B, Wang L, et al
    Emergent drug resistance with integrase strand transfer inhibitor-based regimens: Incidence and risk factors.
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001494.
    PubMed     Text format     Abstract available


  64. VAN BILSEN WP, van den Berg CH, Rijnders BJ, Brinkman K, et al
    Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in hiv-infected patients: a multicenter cohort study.
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001492.
    PubMed     Text format     Abstract available


  65. GONCIULEA A, Wang R, Althoff KN, Palella FJ, et al
    An Increased Rate of Fracture Occurs a Decade Earlier in HIV+ Compared to HIV- men in the Multicenter AIDS Cohort Study (MACS).
    AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001493.
    PubMed     Text format     Abstract available


  66. MAHY M, Penazzato M, Ciaranello A, Mofenson L, et al
    Improving estimates of children living with HIV from the Spectrum AIDS Impact Model.
    AIDS. 2017;31 Suppl 1:S13-S22.
    PubMed     Text format     Abstract available


  67. WILSON KC, Mhangara M, Dzangare J, Eaton JW, et al
    Does nonlocal women's attendance at antenatal clinics distort HIV prevalence surveillance estimates in pregnant women in Zimbabwe?
    AIDS. 2017;31 Suppl 1:S95-S102.
    PubMed     Text format     Abstract available


  68. SHENG B, Marsh K, Slavkovic AB, Gregson S, et al
    Statistical models for incorporating data from routine HIV testing of pregnant women at antenatal clinics into HIV/AIDS epidemic estimates.
    AIDS. 2017;31 Suppl 1:S87-S94.
    PubMed     Text format     Abstract available


  69. MASQUELIER B, Eaton JW, Gerland P, Pelletier F, et al
    Age patterns and sex ratios of adult mortality in countries with high HIV prevalence.
    AIDS. 2017;31 Suppl 1:S77-S85.
    PubMed     Text format     Abstract available


  70. MARSTON M, Nakiyingi-Miiro J, Kusemererwa S, Urassa M, et al
    The effects of HIV on fertility by infection duration: evidence from African population cohorts before antiretroviral treatment availability.
    AIDS. 2017;31 Suppl 1:S69-S76.
    PubMed     Text format     Abstract available


  71. EATON JW, Bao L
    Accounting for nonsampling error in estimates of HIV epidemic trends from antenatal clinic sentinel surveillance.
    AIDS. 2017;31 Suppl 1:S61-S68.
    PubMed     Text format     Abstract available


  72. NIU X, Zhang A, Brown T, Puckett R, et al
    Incorporation of hierarchical structure into estimation and projection package fitting with examples of estimating subnational HIV/AIDS dynamics.
    AIDS. 2017;31 Suppl 1:S51-S59.
    PubMed     Text format     Abstract available


  73. SILHOL R, Gregson S, Nyamukapa C, Mhangara M, et al
    Empirical validation of the UNAIDS Spectrum model for subnational HIV estimates: case-study of children and adults in Manicaland, Zimbabwe.
    AIDS. 2017;31 Suppl 1:S41-S50.
    PubMed     Text format     Abstract available


  74. ANDEREGG N, Johnson LF, Zaniewski E, Althoff KN, et al
    All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up.
    AIDS. 2017;31 Suppl 1:S31-S40.
    PubMed     Text format     Abstract available


  75. MAHIANE SG, Marsh K, Grantham K, Crichlow S, et al
    Improvements in Spectrum's fit to program data tool.
    AIDS. 2017;31 Suppl 1:S23-S30.
    PubMed     Text format     Abstract available


  76. STOVER J, Brown T, Puckett R, Peerapatanapokin W, et al
    Updates to the Spectrum/Estimations and Projections Package model for estimating trends and current values for key HIV indicators.
    AIDS. 2017;31 Suppl 1:S5-S11.
    PubMed     Text format     Abstract available


  77. CASE KK, Gregson S, Mahy M, Ghys PD, et al
    Editorial: methodological developments in the Joint United Nations Programme on HIV/AIDS estimates.
    AIDS. 2017;31 Suppl 1:S1-S4.
    PubMed     Text format    


    March 2017
  78. MONTES ML, Olveira A, Ahumada A, Aldamiz T, et al
    Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001465.
    PubMed     Text format     Abstract available


  79. VALVERDE-VILLEGAS JM, Medeiros RM, Andrade KP, Jacovas VC, et al
    Novel genetic associations and gene-gene interactions of chemokine receptor and chemokine genetic polymorphisms in HIV/AIDS.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001491.
    PubMed     Text format     Abstract available


  80. SORIGUE M, Garcia O, Tapia G, Baptista MJ, et al
    HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001487.
    PubMed     Text format     Abstract available


  81. EKINS S, Mathews P, Saito EK, Diaz N, et al
    alpha-7-nicotinic acetylcholine receptor inhibition by indinavir: implications for cognitive dysfunction in treated HIV disease.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001488.
    PubMed     Text format     Abstract available


  82. BELLAVIA A, Williams PL, Dimeglio LA, Hazra R, et al
    Delay in sexual maturation in perinatally HIV-infected youth is mediated by poor growth.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001486.
    PubMed     Text format     Abstract available


  83. DE MENDOZA C, Cabezas T, Caballero E, Requena S, et al
    HIV-2 Epidemic in Spain - Challenges and Missing Opportunities.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001485.
    PubMed     Text format     Abstract available


  84. EL-DIWANY R, Breitwieser FP, Soliman M, Skaist AM, et al
    Intracellular HIV-1 rna and CD4+ t cell activation in patients starting antiretrovirals.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001480.
    PubMed     Text format     Abstract available


  85. YU C, Seaton M, Letendre S, Heaton R, et al
    Plasma Dickkopf-related Protein 1, an antagonist of the Wnt pathway, is associated with HIV-associated neurocognitive impairment.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001481.
    PubMed     Text format     Abstract available


  86. RAJASURIAR R, Chong ML, Ahmad Bashah NS, Abdul Aziz SA, et al
    Significant health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy in Malaysia.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001475.
    PubMed     Text format     Abstract available


  87. STEKLER JD, Ure G, Dragavon J, Chang M, et al
    Detection of HIV RNA in dried blood spots and oral fluids.
    AIDS. 2017 Mar 29. doi: 10.1097/QAD.0000000000001477.
    PubMed     Text format     Abstract available


  88. LECCA L, Galea J, Contreras CC, Millones AK, et al
    Challenges in TB/HIV management in a country with a concentrated HIV epidemic.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001471.
    PubMed     Text format    


  89. IANTORNO M, Schar M, Soleimanifard S, Brown TT, et al
    Coronary artery endothelial dysfunction is present in HIV positive individuals without significant coronary artery disease.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001469.
    PubMed     Text format     Abstract available


  90. MARSHALL BD, Tate JP, Mcginnis KA, Bryant KJ, et al
    Long-term alcohol use patterns and HIV disease severity: A joint trajectory analysis.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001473.
    PubMed     Text format     Abstract available


  91. HASSAN AS, Pybus OG, Sanders EJ, Albert J, et al
    Defining HIV-1 transmission clusters based on sequence data: a systematic review and perspectives.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001470.
    PubMed     Text format     Abstract available


  92. RYOM L, Mocroft A, Kirk O, Reiss P, et al
    Predictors of eGFR progression, stabilisation or improvement after chronic renal impairment in HIV-positive individuals.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001464.
    PubMed     Text format     Abstract available


  93. WAMBURA M, Mahler H, Grund JM, Larke N, et al
    Increasing voluntary medical male circumcision (VMMC) uptake among adult men in Tanzania: A randomised controlled trial.
    AIDS. 2017 Mar 28. doi: 10.1097/QAD.0000000000001440.
    PubMed     Text format     Abstract available


  94. MAHALINGASIVAM V, Gathogo E, Bramham K, Post FA, et al
    Successful pregnancy in an HIV-positive kidney transplant recipient.
    AIDS. 2017;31:872-873.
    PubMed     Text format    


  95. JINDAL AK, Ahluwalia J, Sharma A, Dhawan S, et al
    HIV-infected children with hepatomegaly and ascites: is there something more than an infection?
    AIDS. 2017;31:870-872.
    PubMed     Text format    


  96. GOEDERT JJ
    The microbiota and HIV: shedding light on dark matters.
    AIDS. 2017;31:863-865.
    PubMed     Text format    



  97. Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe.
    AIDS. 2017;31:835-846.
    PubMed     Text format     Abstract available


  98. PUSKAS CM, Kaida A, Miller CL, Zhang W, et al
    The adherence gap: a longitudinal examination of men's and women's antiretroviral therapy adherence in British Columbia, 2000-2014.
    AIDS. 2017;31:827-833.
    PubMed     Text format     Abstract available


  99. WINCKELMANN A, Barton K, Hiener B, Schlub TE, et al
    Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations.
    AIDS. 2017;31:771-779.
    PubMed     Text format     Abstract available


  100. OZANNE A, Duffau P, Dauchy FA, Rigothier C, et al
    Activation, senescence and inflammation markers in HIV patients: association with renal function.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001461.
    PubMed     Text format     Abstract available


  101. MEIJIDE H, Pertega S, Rodriguez-Osorio I, Castro-Iglesias A, et al
    Increased incidence of cancer observed in HIV/HCV-coinfected patients versus HIV-monoinfected, 1993-2014.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001448.
    PubMed     Text format     Abstract available


  102. PRICE H, Dunn D, Zachary T, Vudriko T, et al
    Hepatitis B serological markers and plasma DNA concentrations: baseline results from the DART trial.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001454.
    PubMed     Text format     Abstract available


  103. GRIESBECK M, Valantin MA, Lacombe K, Samri-Hassimi A, et al
    HCV drives increased type I IFN-associated impairments associated to fibrosis severity in ART-treated HIV-1-HCV coinfected individuals.
    AIDS. 2017 Mar 21. doi: 10.1097/QAD.0000000000001455.
    PubMed     Text format     Abstract available


  104. ROBBINS HA, Strickler HD, Massad LS, Pierce CB, et al
    Cervical cancer screening intervals and management for women living with HIV: A risk benchmarking approach.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001450.
    PubMed     Text format     Abstract available


  105. JIN F, Roberts JM, Grulich AE, Poynten IM, et al
    The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001462.
    PubMed     Text format     Abstract available


  106. SAMUELS R, Bayerri CR, Sayer JA, Price DA, et al
    TDF associated renal tubular dysfunction: non-invasive assessment of mitochondrial injury.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001466.
    PubMed     Text format     Abstract available


  107. MOORE CB, Capparelli EV, Samson P, Bwakura-Dangarembizi M, et al
    CYP2B6 Genotype-directed dosing is required for optimal efavirenz exposure in children 3 to 36 months with HIV infection.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001463.
    PubMed     Text format     Abstract available


  108. MONTGOMERY ET, van der Straten A, Chitukuta M, Reddy K, et al
    "It's inside my body and it's mine".
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001452.
    PubMed     Text format     Abstract available


  109. MUKANDAVIRE C, Low A, Mburu G, Trickey A, et al
    Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001458.
    PubMed     Text format     Abstract available


  110. DUTTA A, Uno H, Holman A, Lorenz DR, et al
    Long-term nitrite inhalant exposure and cancer risk in men who have sex with men: a prospective cohort study.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001451.
    PubMed     Text format     Abstract available


  111. GAGNEUX-BRUNON A, Rochereau N, Botelho-Nevers E, Lucht F, et al
    Humoral responses against HIV in male genital tract: role in sexual transmission and perspectives for preventive strategies.
    AIDS. 2017 Mar 18. doi: 10.1097/QAD.0000000000001460.
    PubMed     Text format     Abstract available


  112. MCALLISTER J, Towns JM, Mcnulty A, Pierce AB, et al
    Dolutegravir with tenofovir disoproxil fumarate - emtricitabine as HIV post-exposure prophylaxis in gay and bisexual men.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001447.
    PubMed     Text format     Abstract available


  113. MANGAL TD
    Joint estimation of CD4 progression and survival in untreated individuals with HIV-1 infection: A pooled analysis of data from 25 countries.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001437.
    PubMed     Text format     Abstract available


  114. MOTA TM, Rasmussen TA, Rhodes A, Tennakoon S, et al
    No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001442.
    PubMed     Text format     Abstract available


  115. YANG OO, Cumberland WG, Escobar R, Liao D, et al
    Demographics and natural history of HIV-1-infected spontaneous controllers of viremia: extremes on a continuum.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001443.
    PubMed     Text format     Abstract available


  116. KANTHULA R, Rossouw T, Feucht UD, Van Dyk G, et al
    Persistence of HIV-drug-resistance among South African Children given Nevirapine to Prevent Mother-to-Child-Transmission.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001446.
    PubMed     Text format     Abstract available


  117. KONG X, Kigozi G, Ssekasanvu J, Nalugoda F, et al
    Medical male circumcision coverage in Rakai, Uganda.
    AIDS. 2017;31:735-737.
    PubMed     Text format     Abstract available


  118. CZAICKI NL, Holmes CB, Sikazwe I, Bolton C, et al
    Nonadherence to antiretroviral therapy among HIV-infected patients in Zambia is concentrated among a minority of patients and is highly variable across clinics.
    AIDS. 2017;31:689-696.
    PubMed     Text format     Abstract available


  119. HARAWA NT, Holloway IW, Leibowitz A, Weiss R, et al
    Serious concerns regarding a meta-analysis of preexposure prophylaxis use and STI acquisition.
    AIDS. 2017;31:739-740.
    PubMed     Text format    


  120. LINNEMAYR S, Stecher C, Mukasa B
    Behavioral economic incentives to improve adherence to antiretroviral medication.
    AIDS. 2017;31:719-726.
    PubMed     Text format     Abstract available


  121. TOMESCU C, Tebas P, Montaner LJ
    IFN-alpha augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
    AIDS. 2017;31:613-622.
    PubMed     Text format     Abstract available


  122. TOBIN SC
    Evaluating the generalizability of clinical trials of direct-acting antivirals for HIV/HCV-coinfection.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001439.
    PubMed     Text format    


  123. BURGOS J, Curran A, Landolfi S, Guelar A, et al
    Risk factors of high-grade anal intraepithelial neoplasia recurrence in HIV-infected men who have sex with men.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001433.
    PubMed     Text format     Abstract available


  124. MARCUS JL, Leyden WA, Chao CR, Horberg MA, et al
    Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001434.
    PubMed     Text format     Abstract available


  125. TORIBIO M, Fitch KV, Sanchez L, Burdo TH, et al
    Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in intrepid: a randomized trial in HIV.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001427.
    PubMed     Text format     Abstract available


  126. KIRKEGAARD-KLITBO DM, Mejer N, Knudsen TB, Moller HJ, et al
    Soluble CD163 Predicts Incident Chronic Lung, Kidney and Liver Disease in HIV Infection.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001432.
    PubMed     Text format     Abstract available


  127. MAHEU-GIROUX M, Tanser F, Boily MC, Pillay D, et al
    Determinants of time from HIV infection to linkage-to-care in rural KwaZulu-Natal, South Africa.
    AIDS. 2017 Mar 1. doi: 10.1097/QAD.0000000000001435.
    PubMed     Text format     Abstract available


    February 2017
  128. BENGTSON AM, Pence BW, Moore R, Mimiaga MJ, et al
    The relationship between ever reporting depressive symptoms and all-cause mortality in a cohort of HIV-infected adults in routine care.
    AIDS. 2017 Feb 27. doi: 10.1097/QAD.0000000000001431.
    PubMed     Text format     Abstract available


  129. BRYANT AK, Moore DJ, Burdo TH, Lakritz JR, et al
    Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection.
    AIDS. 2017 Feb 27. doi: 10.1097/QAD.0000000000001425.
    PubMed     Text format     Abstract available


  130. VESA J, Chaillon A, Wagner GA, Anderson CM, et al
    Increased HIV-1 superinfection risk in carriers of specific human leukocyte antigen alleles.
    AIDS. 2017 Feb 27. doi: 10.1097/QAD.0000000000001445.
    PubMed     Text format     Abstract available



  131. First evidence of intra-familial transmission of an HIV-1 M/O intergroup recombinant virus: Erratum.
    AIDS. 2017;31:601.
    PubMed     Text format    


  132. KASIRYE RP, Grosskurth H, Munderi P, Levin J, et al
    Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults.
    AIDS. 2017;31:577-582.
    PubMed     Text format     Abstract available


  133. COMBES JD, Clifford GM, Egger M, Cavassini M, et al
    Human papillomavirus antibody response following HAART initiation among MSM.
    AIDS. 2017;31:561-569.
    PubMed     Text format     Abstract available


  134. TAKUVA S, Brown AE, Pillay Y, Delpech V, et al
    The continuum of HIV care in South Africa: implications for achieving the second and third UNAIDS 90-90-90 targets.
    AIDS. 2017;31:545-552.
    PubMed     Text format     Abstract available


  135. JOSE S, Nelson M, Phillips A, Chadwick D, et al
    Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir.
    AIDS. 2017;31:485-492.
    PubMed     Text format     Abstract available


  136. MANDAL S, Prathipati PK, Kang G, Zhou Y, et al
    Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission.
    AIDS. 2017;31:469-476.
    PubMed     Text format     Abstract available


  137. RAFIEI N, Woolley I, Korman TM, Chibo D, et al
    Integrase-resistant HIV in an antiretroviral-naive patient in Australia.
    AIDS. 2017;31:598-600.
    PubMed     Text format    


  138. DENNEMAN L, Cohen S, Godfried MH, van Leeuwen E, et al
    In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply.
    AIDS. 2017;31:596-598.
    PubMed     Text format    


  139. WEN Y, Li JZ
    Post-treatment HIV controllers or spontaneous controllers in disguise?
    AIDS. 2017;31:587-589.
    PubMed     Text format    


    January 2017
  140. LACHATRE M, Pasquet A, Ajana F, Soudan B, et al
    HIV and hypogonadism: a new challenge for young-aged and middle-aged men on effective antiretroviral therapy.
    AIDS. 2017;31:451-453.
    PubMed     Text format     Abstract available


  141. SCHUSTER C, Binder C, Strassl R, Aichelburg MC, et al
    Impact of HIV infection and antiretroviral treatment on N-terminal prohormone of brain natriuretic peptide as surrogate of myocardial function.
    AIDS. 2017;31:395-400.
    PubMed     Text format     Abstract available


  142. REID M, Ma Y, Scherzer R, Price JC, et al
    Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.
    AIDS. 2017;31:385-393.
    PubMed     Text format     Abstract available



  143. One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.
    AIDS. 2017;31:375-384.
    PubMed     Text format     Abstract available


  144. AKUA T, Rahav G, Saragani Y, Hizi A, et al
    Removal of ribonucleotides by p53 protein incorporated during DNA synthesis by HIV-1 reverse transcriptase.
    AIDS. 2017;31:343-353.
    PubMed     Text format     Abstract available


  145. BORGHETTI A, Baldin G, Capetti A, Sterrantino G, et al
    Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients.
    AIDS. 2017;31:457-459.
    PubMed     Text format    


  146. AHMAD A, Rinaldo CR
    A novel anti-HIV immunotherapy to cure HIV.
    AIDS. 2017;31:447-449.
    PubMed     Text format    


  147. SORIANO V, Sherman KE, Barreiro P
    Hepatitis Delta and HIV Infection.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001424.
    PubMed     Text format     Abstract available


  148. SU S, Wang Q, Xu W, Yu F, et al
    A novel HIV-1 gp41 tripartite model for rational design of HIV-1 fusion inhibitors with improved antiviral activity.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001415.
    PubMed     Text format     Abstract available


  149. PATEL EU, Gianella S, Newell K, Tobian AA, et al
    Elevated cytomegalovirus IgG antibody levels are associated with HIV-1 disease progression and immune activation.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001412.
    PubMed     Text format     Abstract available


  150. PINATO DJ, Pria AD, Sharma R, Bower M, et al
    Hepatocellular carcinoma: an evolving challenge in viral hepatitis and HIV co-infection.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001422.
    PubMed     Text format     Abstract available


  151. LIFSON AR, Grund B, Gardner EM, Kaplan R, et al
    Improved quality of life with immediate initiation of antiretroviral therapy in the strategic timing of antiretroviral therapy trial.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001417.
    PubMed     Text format     Abstract available


  152. CHEHOUD C, Stieh DJ, Bailey AG, Laughlin AL, et al
    Associations of the vaginal microbiota with HIV infection, bacterial vaginosis and demographic factors.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001421.
    PubMed     Text format     Abstract available


  153. SU T, Mutsaerts HJ, Caan MW, Wit FW, et al
    Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001414.
    PubMed     Text format     Abstract available


  154. CROOME N, Ahluwalia M, Hughes LD, Abas M, et al
    Patient-reported barriers and facilitators to antiretroviral adherence in Sub-Saharan Africa: a systematic review.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001416.
    PubMed     Text format     Abstract available


  155. JOSHI PH, Miller PE, Martin SS, Jones SR, et al
    Greater remnant lipoprotein cholesterol reduction with pitavastatin compared to pravastatin in HIV-infected patients: The INTREPID trial.
    AIDS. 2017 Jan 24. doi: 10.1097/QAD.0000000000001423.
    PubMed     Text format     Abstract available


  156. NOWAK RG, Bentzen SM, Ravel J, Crowell TA, et al
    Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected men who have sex with men (MSM) in Nigeria.
    AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001409.
    PubMed     Text format     Abstract available


  157. PUSKAS CM, Kaida A, Miller CL, Zhang W, et al
    The gender gap: a longitudinal examination of men's and women's art adherence in british columbia, 2000-2014.
    AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001408.
    PubMed     Text format     Abstract available



  158. Timing of cART initiation in Male and Female Migrants Living with HIV in Western Europe: an observational cohort study (1997-2013).
    AIDS. 2017 Jan 21. doi: 10.1097/QAD.0000000000001411.
    PubMed     Text format     Abstract available


  159. WINCKELMANN A, Barton K, Hiener B, Schlub TE, et al
    Romidepsin-induced HIV-1 viremia during effective ART contains identical viral sequences with few deleterious mutations.
    AIDS. 2017 Jan 19. doi: 10.1097/QAD.0000000000001400.
    PubMed     Text format     Abstract available


  160. MCCOY SI, Njau PF, Fahey C, Kapologwe N, et al
    Cash vs. food assistance to improve adherence to antiretroviral therapy among HIV-infected adults in Tanzania: a randomized trial.
    AIDS. 2017 Jan 19. doi: 10.1097/QAD.0000000000001406.
    PubMed     Text format     Abstract available


  161. KRAFT JC, McConnachie LA, Koehn J, Kinman L, et al
    Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001405.
    PubMed     Text format     Abstract available


  162. MONTOYA JL, Iudicello J, Oppenheim HA, Fazeli PL, et al
    Coagulation imbalance and neurocognitive functioning in older HIV+ adults on suppressive antiretroviral therapy.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001404.
    PubMed     Text format     Abstract available


  163. BALINANG JM, Masvekar RR, Hauser KF, Knapp PE, et al
    Productive infection of human neural progenitor cells by R5 tropic HIV-1: opiate co-exposure heightens infectivity and functional vulnerability.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001398.
    PubMed     Text format     Abstract available


  164. SEREMBA E, Ssempijja V, Kalibbala S, Gray RH, et al
    Hepatitis B incidence and prevention with antiretroviral therapy among HIV positive individuals in Rakai, Uganda.
    AIDS. 2017 Jan 17. doi: 10.1097/QAD.0000000000001399.
    PubMed     Text format     Abstract available


  165. BAI F, Iannuzzi F, Merlini E, Borghi L, et al
    Clinical and viro-immunological correlates of HIV associated neurocognitive disorders (HAND) in a cohort of antiretroviral-naive HIV-infected patients.
    AIDS. 2017;31:311-314.
    PubMed     Text format     Abstract available


  166. HOST KM, Horner MJ, van der Gronde T, Moses A, et al
    Kaposi's sarcoma in Malawi: a continued problem for HIV-positive and HIV-negative individuals.
    AIDS. 2017;31:318-319.
    PubMed     Text format    


  167. BRENNAN AT, Bonawitz R, Gill CJ, Thea DM, et al
    Prioritizing health outcomes of HIV-exposed, uninfected children in low and middle-income countries: response to Powis et al.
    AIDS. 2017;31:317.
    PubMed     Text format    


  168. POWIS KM, Slogrove AL, Mofenson L
    Protecting the health of our AIDS-free generation: beyond prevention of mother-to-child HIV transmission.
    AIDS. 2017;31:315-316.
    PubMed     Text format    


  169. CACERES CF
    Educational attainment and intersectionality in the response to HIV antiretroviral treatment in Europe.
    AIDS. 2017;31:305-307.
    PubMed     Text format    


  170. SAMJI H, Zhang W, Eyawo O, Jabbari S, et al
    Rates and predictors of injury in a population-based cohort of people living with HIV.
    AIDS. 2017;31:295-304.
    PubMed     Text format     Abstract available


  171. OMENGE ORANG'O E, Liu T, Christoffersen-Deb A, Itsura P, et al
    Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
    AIDS. 2017;31:233-240.
    PubMed     Text format     Abstract available


  172. CALZA L, Magistrelli E, Colangeli V, Borderi M, et al
    Significant association between statin-associated myalgia and vitamin d deficiency among treated hiv-infected patients.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001397.
    PubMed     Text format     Abstract available


  173. NUNN AS, Brinkley-Rubinstein L, Oldenburg CE, Mayer KH, et al
    Defining the HIV Pre-Exposure Prophylaxis Care Continuum.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001385.
    PubMed     Text format    


  174. SABIN CA, Howarth A, Jose S, Hill T, et al
    Association between engagement in-care and mortality in HIV-positive persons: a cohort study.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001373.
    PubMed     Text format     Abstract available


  175. WEINBERG A, Mussi-Pinhata MM, Yu Q, Cohen RA, et al
    Excess respiratory viral infections and low antibody responses among HIV-exposed, uninfected infants.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001393.
    PubMed     Text format     Abstract available


  176. TOMESCU C, Tebas P, Montaner LJ
    IFN-alpha augments NK-mediated antibody-dependent cellular cytotoxicity (ADCC) of HIV-1 infected autologous CD4+ T cells regardless of MHC-I downregulation.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001380.
    PubMed     Text format     Abstract available


  177. FERREIRA MP, Coghill AE, Chaves CB, Bergmann A, et al
    Outcomes of cervical cancer among HIV-infected and uninfected women treated at the Brazilian National Institute of Cancer (2001-2013).
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001367.
    PubMed     Text format     Abstract available


  178. LINNEMAYR S, Stecher C, Mukasa B
    Behavioral economic incentives to improve adherence to antiretrovirals: early evidence from a randomized controlled trial in Uganda.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001387.
    PubMed     Text format     Abstract available


  179. MARTIN GE, Gossez M, Williams JP, Stohr W, et al
    Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001382.
    PubMed     Text format     Abstract available


  180. MAKAROVA N, Henning T, Taylor A, Dinh C, et al
    Topical tenofovir protects against vaginal SHIV infection in macaques co-infected with chlamydia trachomatis and trichomonas vaginalis.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001389.
    PubMed     Text format     Abstract available


  181. TINAGO W, Cotter AG, Sabin C, Macken A, et al
    Predictors of longitudinal change in bone mineral density in a cohort of HIV-positive and negative subjects.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001372.
    PubMed     Text format     Abstract available


  182. ANGIN M, Fathi A, King M, Ledoux MB, et al
    Acute HIV-1 infection is associated with increased plasma levels of heme oxygenase-1 (HO-1) and presence of HO-1-specific regulatory T cells.
    AIDS. 2017 Jan 4. doi: 10.1097/QAD.0000000000001390.
    PubMed     Text format     Abstract available


  183. STREECK H, Verheyen J, Storim J, Dittmer U, et al
    Pre-exposure prophylaxis failure with tenofovir disoproxil.
    AIDS. 2017;31:176-177.
    PubMed     Text format    


  184. SPECTOR SA, Rappaport J
    HIV cure strategists: ignore the central nervous system at your patients' peril.
    AIDS. 2017;31:167-168.
    PubMed     Text format    



  185. Coinfection with HIV and hepatitis C virus in 229 children and young adults living in Europe.
    AIDS. 2017;31:127-135.
    PubMed     Text format     Abstract available


  186. NEWSUM AM, Ho CK, Lieveld FI, van de Laar TJ, et al
    The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands.
    AIDS. 2017;31:105-112.
    PubMed     Text format     Abstract available


  187. M LE ROUX S, Jao J, Brittain K, Phillips TK, et al
    Tenofovir exposure in utero and linear growth in HIV-exposed, uninfected infants.
    AIDS. 2017;31:97-104.
    PubMed     Text format     Abstract available


  188. GAMA L, Abreu CM, Shirk EN, Price SL, et al
    Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques.
    AIDS. 2017;31:5-14.
    PubMed     Text format     Abstract available


  189. BRENNAN AT, Davies MA, Bor J, Wandeler G, et al
    Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?
    AIDS. 2017;31:147-157.
    PubMed     Text format     Abstract available


    December 2016
  190. VENKATACHARI NJ, Jain S, Walker L, Bivalkar-Mehla S, et al
    Transcriptome analyses identify key cellular factors associated with HIV-1 associated neuropathogenesis in infected men.
    AIDS. 2016 Dec 21. doi: 10.1097/QAD.0000000000001379.
    PubMed     Text format     Abstract available


  191. PETERS L, Cozzi-Lepri A
    Is Response to Anti-HCV Treatment Predictive of Mortality in HCV/HIV Positive Patients?
    AIDS. 2016 Dec 21. doi: 10.1097/QAD.0000000000001378.
    PubMed     Text format     Abstract available


  192. BRENNER BG, Ibanescu RI, Hardy I, Stephens D, et al
    Large cluster outbreaks sustain the HIV epidemic among men having sex with men (MSM) in Quebec from 2002 to 2015.
    AIDS. 2016 Dec 21. doi: 10.1097/QAD.0000000000001383.
    PubMed     Text format     Abstract available


  193. HARPER KN
    New mouse models provide insights into how to design a more effective HIV vaccine.
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001371.
    PubMed     Text format    


  194. HARPER KN
    Do HIV-infected children who do not develop AIDS hold clues to a cure?
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001370.
    PubMed     Text format    


  195. HARPER KN
    To break patent or not to break patent: What is in the best interests of HIV patients in low-income countries?
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001369.
    PubMed     Text format    


  196. DILLON SM, Kibbie J, Lee EJ, Guo K, et al
    Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.
    AIDS. 2016 Dec 19. doi: 10.1097/QAD.0000000000001366.
    PubMed     Text format     Abstract available


  197. KROIDL A, Ello F, Mgaya J, Lennemann T, et al
    Virological efficacy of 24-weeks fozivudine based regimen in ART-naive patients from tanzania and cote d'Ivoire.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  198. MORRIS A, Fitzpatrick M, Bertolet M, Qin S, et al
    Use of rosuvastatin in HIV-associated chronic obstructive pulmonary disease: A randomized pilot study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  199. SERRANO-VILLAR S, Vasquez-Dominguez E, Perez-Molina JA, Sainz T, et al
    HIV, HPV and microbiota: partners in crime?
    AIDS. 2016.
    PubMed     Text format     Abstract available


  200. DIRAJLAL-FARGO S, Alam SM, Sattar A, Kulkarni M, et al
    Comprehensive assessment of the arginine pathway and its relationship to inflammation in HIV.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  201. LUNSKY Y, Durbin A, Brown HK, Bansal S, et al
    Health profiles and associated service use among adults with HIV and intellectual and developmental disabilities.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  202. MERCHANTE N, Rivero-Juarez A, Tellez F, Merino D, et al
    Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  203. NELSON KN, Hui Q, Rimland D, Xu K, et al
    Identification of HIV infection-related DNA methylation sites and advanced epigenetic aging in HIV+, treatment-naive U.S. veterans.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    November 2016
  204. WESTREICH D, Cates J, Cohen M, Weber KM, et al
    Smoking, HIV, and risk of pregnancy loss.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  205. PAZ-BAILEY G, Wejnert C, Mendoza MC, Prejean J, et al
    Response to diversification of risk-reduction strategies and reduced threat of HIV may explain increases in condomless sex.
    AIDS. 2016;30:2900-2901.
    PubMed     Text format    


  206. KIPPAX S, Holt M
    Diversification of risk reduction strategies and reduced threat of HIV may explain increases in condomless sex.
    AIDS. 2016;30:2898-2899.
    PubMed     Text format    


  207. AUTRAN B, Pogliaghi M, Katlama C
    Reply to Immunometabolism may provide insights into novel mechanisms of HIV reservoir persistence.
    AIDS. 2016;30:2896-2898.
    PubMed     Text format    


  208. PALMER CS, Crowe SM
    Immunometabolism may provide new insights into novel mechanisms of HIV reservoir persistence.
    AIDS. 2016;30:2895-2896.
    PubMed     Text format    


  209. DARCIS G, Coombs RW, Van Lint C
    Exploring the anatomical HIV reservoirs: role of the testicular tissue.
    AIDS. 2016;30:2891-2893.
    PubMed     Text format    


  210. VASYLYEVA TI, Friedman SR, Lourenco J, Gupta S, et al
    Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects.
    AIDS. 2016;30:2885-2890.
    PubMed     Text format     Abstract available


  211. DE BOER MG, van den Berk GE, van Holten N, Oryszcyn JE, et al
    Intolerance of dolutegravir-containing combination antiretroviral therapy regimens in real-life clinical practice.
    AIDS. 2016;30:2831-2834.
    PubMed     Text format     Abstract available


  212. TORT O, Sanchez-Palomino S, Escriba T, Calvo C, et al
    omega-3 supplementation in HIV-1-infected individuals with unsuppressed viral load: cause for caution?
    AIDS. 2016;30:2733-2735.
    PubMed     Text format    


  213. BRENNER B, Wainberg MA
    We need to use the best antiretroviral drugs worldwide to prevent HIV drug resistance.
    AIDS. 2016;30:2725-2727.
    PubMed     Text format    


  214. KUNKEL A, Crawford FW, Shepherd J, Cohen T, et al
    Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.
    AIDS. 2016;30:2715-2723.
    PubMed     Text format     Abstract available


  215. KIM AA, Mukui I, Young PW, Mirjahangir J, et al
    Undisclosed HIV infection and antiretroviral therapy use in the Kenya AIDS indicator survey 2012: relevance to national targets for HIV diagnosis and treatment.
    AIDS. 2016;30:2685-2695.
    PubMed     Text format     Abstract available


  216. LODI S, Sharma S, Lundgren JD, Phillips AN, et al
    The per-protocol effect of immediate versus deferred antiretroviral therapy initiation.
    AIDS. 2016;30:2659-2663.
    PubMed     Text format     Abstract available


  217. DE BIASI S, Bianchini E, Nasi M, Digaetano M, et al
    Th1 and Th17 proinflammatory profile characterizes invariant natural killer T cells in virologically suppressed HIV+ patients with low CD4+/CD8+ ratio.
    AIDS. 2016;30:2599-2610.
    PubMed     Text format     Abstract available


  218. VANCE DE
    Interpreting the influence of race and cognitive activity on neurocognition in adults aging with HIV.
    AIDS. 2016.
    PubMed     Text format    


  219. YOUNAS M, Carrat F, Finge S, Desaint C, et al
    Immune activation, smoking, and vaccine response.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  220. VIGANO S, Negron JJ, Tse S, Chowdhury FZ, et al
    HLA-G+ HIV-1-specific CD8 T cells are associated with HIV-1 immune control.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  221. BUTTERFIELD TR, Hanna DB, Kaplan RC, Kizer JR, et al
    Increased glucose transporter-1 EXPRESSION on intermediate monocytes from HIV-infected women with subclinical cardiovascular disease.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  222. GOSSELIN A, Wiche Salinas TR, Planas D, Wacleche VS, et al
    HIV persists in CCR6+CD4+ T-cells from colon and blood during antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  223. KRUEGER KR, Adeyemi O, Leurgans S, Shah RC, et al
    Association of cognitive activity and neurocognitive function in blacks and whites with HIV.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  224. SELVA KJ, Kent SJ, Parsons MS
    Modulation of innate and adaptive cellular immunity relevant to HIV-1 vaccine design by seminal plasma.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  225. SUDFELD CR, Kaaya S, Gunaratna NS, Mugusi F, et al
    Depression at antiretroviral therapy initiation and clinical outcomes among a cohort of Tanzanian women living with HIV.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  226. SHIAU S, Strehlau R, Technau KG, Patel F, et al
    Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  227. GUELER A, Moser A, Calmy A, Gunthard HF, et al
    Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  228. MOFENSON LM, Baggaley RC, Mameletzis I
    Tenofovir Disoproxil Fumarate Safety for Women and their Infants during Pregnancy and Breastfeeding: Systematic Review.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  229. ORANG'O O, Liu T, Christoffersen-Deb A, Itsura P, et al
    Use of VIA, Pap smear, or HR-HPV testing in women living with HIV/AIDS for post-treatment cervical cancer screening: same tests, different priorities.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  230. GREEN N, Hoenigl M, Chaillon A, Anderson CM, et al
    Partner services in adults with acute and early HIV infection, San Diego, 1996-2014.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  231. KARDASHIAN A, Ma Y, Scherzer R, Price JC, et al
    Sex differences in the association of HIV infection with hepatic steatosis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  232. BRAND D, Capsec J, Chaillon A, Cazein F, et al
    HIV surveillance combining an assay for identification of very recent infection and phylogenetic analyses on dried spots.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  233. NAKAGAWA F, Phillips A
    An epidemiological modelling study to estimate the composition of HIV-positive populations including migrants from endemic settings: an application in the UK.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  234. SAMJI H, Zhang W, Eyawo O, Jabbari S, et al
    Rates and predictors of injury in a population-based cohort of people living with HIV: trends and disparities from 1996 to 2013.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  235. CHRISTOPOULOS K, Hartogensis W, Glidden DV, Pilcher CD, et al
    The lorenz curve: a novel method for understanding viral load distribution at the population level.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  236. PELUSO MJ, Valcour V, Phanuphak N, Ananworanich J, et al
    Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    October 2016
  237. MIRKOVIC KR, Rivadeneira ED, Broyles LN
    Children and alternative service delivery models: a case for inclusion.
    AIDS. 2016;30:2569-2570.
    PubMed     Text format    


  238. UNAL G, Mourez T, Leoz M, Alessandri-Gradt E, et al
    First report of transmission of a highly resistant strain of HIV-1 group O.
    AIDS. 2016;30:2565-2568.
    PubMed     Text format    


  239. ZOLLA-PAZNER S
    Non-neutralizing antibody functions for protection and control HIV in humans and SIV and SHIV in non-human primates.
    AIDS. 2016;30:2551-2553.
    PubMed     Text format    


  240. BAUTISTA-ARREDONDO S, Sosa-Rubi SG, Opuni M, Contreras-Loya D, et al
    Costs along the service cascades for HIV testing and counselling and prevention of mother-to-child transmission.
    AIDS. 2016;30:2495-2504.
    PubMed     Text format     Abstract available


  241. OLIVER NT, Hartman CM, Kramer JR, Chiao EY, et al
    Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals.
    AIDS. 2016;30:2469-2476.
    PubMed     Text format     Abstract available


  242. FRIEDMAN EE, Duffus WA
    Chronic health conditions in Medicare beneficiaries 65 years and older with HIV infection.
    AIDS. 2016;30:2529-2536.
    PubMed     Text format     Abstract available


  243. MARSTON M, Nakiyingi-Miiro J, Kusemererwa S, Urassa M, et al
    The effects of HIV on fertility by infection duration: evidence from African population cohorts before ART availability: Fertility by duration of HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  244. BRENNAN AT, Davies MA, Bor J, Wandeler G, et al
    Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?
    AIDS. 2016.
    PubMed     Text format     Abstract available


  245. SPRENGER HG, Bierman WF, Martes MI, Graaff R, et al
    Skin advanced glycation end products in HIV infection are increased and predictive of development of cardiovascular events.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  246. HARPER KN
    New research on using CRISPR/Cas9 to treat HIV.
    AIDS. 2016.
    PubMed     Text format    


  247. GIANELLA S, Taylor J, Brown TR, Kaytes A, et al
    Can research at the end-of-life be a useful tool to advance HIV cure?
    AIDS. 2016.
    PubMed     Text format     Abstract available


  248. M LE ROUX S, Jao J, Brittain K, Phillips TK, et al
    Tenofovir exposure in utero and linear growth in HIV exposed, uninfected infants: a prospective study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  249. CHOPERA DR, Ntale R, Ndabambi N, Garrett N, et al
    Early evolution of HLA-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C infected women.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  250. MERCHANTE N, Ibarra S, Revollo B, Rodriguez-Arrondo F, et al
    Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients (RIS-HEP12/GEHEP-002 study).
    AIDS. 2016.
    PubMed     Text format     Abstract available


  251. TAKEMOTO JK, Miller TL, Wang J, Jacobson DL, et al
    Insulin Resistance in HIV-Infected Youth is associated with decreased mitochondrial respiration.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  252. KELLY HA, Sawadogo B, Chikandiwa A, Segondy M, et al
    Epidemiology of High-risk Human Papillomavirus and Cervical Lesions in African women living with HIV/AIDS: Effect of Anti-Retroviral Therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  253. VAN DER WERF MJ, Kodmon C, Zucs P, Hollo V, et al
    Tuberculosis and HIV co-infection in Europe: looking at one reality from two angles.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  254. DARCIS G, Bouchat S, Kula A, Van Driessche B, et al
    Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  255. AHRENSTORF G, Low HZ, Kniesch K, Ordonez D, et al
    LILRA3 deletion is a genetic risk factor of HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  256. HARPER KN
    The 2nd Durban Declaration draws attention to progress in the fight against HIV and work yet to do.
    AIDS. 2016.
    PubMed     Text format    


  257. HARPER KN
    HIV-altered gut microbiome may be driving disease progression.
    AIDS. 2016.
    PubMed     Text format    


  258. DILLON SM, Frank DN, Wilson CC
    The gut microbiome and HIV-1 pathogenesis: a two way street.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  259. DOBRA A, Barnighausen T, Vandormael A, Tanser F, et al
    Space-time migration patterns and risk of HIV acquisition in rural South Africa: a population-based cohort study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    September 2016
  260. GUPTA SK, Kamendulis LM, Clauss MA, Liu Z, et al
    A randomized, placebo-controlled pilot trial of N-acetylcysteine on oxidative stress and endothelial function in HIV-infected older adults receiving antiretroviral treatment.
    AIDS. 2016;30:2389-91.
    PubMed     Text format    


  261. LUZURIAGA K, Persaud D
    Treatment interruption after early-treated perinatal HIV-1 infection.
    AIDS. 2016;30:2381-3.
    PubMed     Text format    


  262. BREW BJ
    Has HIV-associated neurocognitive disorders now transformed into vascular cognitive impairment?
    AIDS. 2016;30:2379-80.
    PubMed     Text format    


  263. DE BOER M, van den Berk G, van Holten N, Oryszczyn J, et al
    Intolerance of dolutegravir containing cART regimens in real life clinical practice.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  264. TAO J, Qian HZ, Kipp AM, Ruan Y, et al
    Effects of depression and anxiety on antiretroviral therapy adherence among newly diagnosed hiv-infected chinese men who have sex with men.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  265. BEDOYA LM, Beltran M, Obregon-Calderon P, Garcia-Perez J, et al
    Hydroxytyrosol. a new class of microbicide displaying broad anti HIV-1 activity.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  266. SCHERZER R, Heymsfield SB, Rimland D, Powderly WG, et al
    Association of serum albumin and AST with 5-year all-cause mortality in HIV/HCV coinfection and HIV monoinfection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  267. SOEPNEL LM, Norris SA, Schrier VJ, Browne JL, et al
    The association between HIV, antiretroviral therapy and gestational diabetes mellitus: a systematic review and meta-analysis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  268. THORNE C, Turkova A, Indolfi G, Venturini E, et al
    Co-infection with HIV and HCV in 229 children and young adults living in Europe.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  269. MURI L, Gamell A, Ntamatungiro AJ, Glass TR, et al
    Development of HIV drug resistance and therapeutic failure in children and adolescents in rural tanzania - an emerging public health concern.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  270. JENABIAN MA, Costiniuk CT, Mehraj V, Ghazawi FM, et al
    Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  271. MUKHERJEE PK, Chen H, Patton LL, Evans S, et al
    Topical gentian violet compared to nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1 Infected participants.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  272. GUARDO AC, Joe PT, Miralles L, Bargallo ME, et al
    Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix).
    AIDS. 2016.
    PubMed     Text format     Abstract available


  273. TELWATTE S, Brumme CJ, Hearps AC, Latham CF, et al
    Increasing Prevalence of Synonymous Mutations K65K and K66K in HIV-1 subtype B reverse transcriptase.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  274. DE BIASI S, Bianchini E, Nasi M, Digaetano M, et al
    Th1 and Th17 pro-inflammatory profile characterizes iNKT cells in virologically suppressed HIV+ patients with low CD4/CD8 ratio.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  275. DEL AMO J
    Inequalities by educational level in response to combination antiretroviral treatment and survival in HIV-positive men and women in Europe (1996-2013): a collaborative cohort study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  276. PRENDERGAST AJ, Bwakura-Dangarembizi M, Mugyenyi P, Lutaakome J, et al
    Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  277. GAMA L, Abreu CM, Shirk EN, Price SL, et al
    Reactivation of SIV reservoirs in the brain of virally suppressed macaques.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  278. ALAEI K, Paynter CA, Juan SC, Alaei A, et al
    Using PrEP, losing condoms? PrEP promotion may undermine safe sex.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  279. NEWSUM AM, Ho CK, Lieveld FI, Van De Laar TJ, et al
    The hepatitis C virus NS3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  280. LEVIN MJ, Lindsey JC, Kaplan SS, Schimana W, et al
    Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  281. PINES HA, Wertheim JO, Liu L, Garfein RS, et al
    Concurrency and HIV transmission network characteristics among men who have sex with men with recent HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  282. GAY CL, Willis SJ, Cope AB, Kuruc JD, et al
    Fixed dose combination emtricitabine/tenofovir/efavirenz initiated during Acute HIV Infection; 96-week efficacy and durability.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  283. HLEYHEL M, Goujon S, Sibiude J, Blanche S, et al
    In utero exposure to NELFINAVIR-EMS.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  284. KUZNIK A, Iliyasu G, Habib AG, Musa BM, et al
    Initiation of antiretroviral therapy based on the 2015 WHO guidelines: A cost-effectiveness analysis in Nigeria, South Africa, Uganda and India.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  285. RYLANCE J, Mchugh G, Metcalfe J, Mujuru H, et al
    Chronic lung disease in HIV-infected children established on antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  286. GRANT PM, Kitch D, McComsey GA, Collier AC, et al
    Long-term body composition changes in antiretroviral-treated HIV-infected individuals.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  287. SCHNEIDER JA, Kozloski M, Michaels S, Skaathun B, et al
    Criminal justice involvement history is associated with better HIV care continuum metrics among a population-based sample of young black men who have sex with men.
    AIDS. 2016.
    PubMed     Text format     Abstract available



  288. The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption: Erratum.
    AIDS. 2016;30:2259.
    PubMed     Text format    


  289. VASSALLO M, De Monte A, Durant J, Dunais B, et al
    Selection of the R263K mutation to dolutegravir in cerebrospinal fluid HIV-1 virus in one patient with HIV-associated neurocognitive disorders.
    AIDS. 2016;30:2257-8.
    PubMed     Text format    


  290. CAMASMIE HR, Leda SB, Lupi O, Lima RB, et al
    Chronic herpetic whitlow as the first manifestation of HIV infection.
    AIDS. 2016;30:2254-6.
    PubMed     Text format    


  291. CUERVO G, Simonetti AF, Alegre O, Sanchez-Salado JC, et al
    Toxoplasma myocarditis: a rare but serious complication in an HIV-infected late presenter.
    AIDS. 2016;30:2253-4.
    PubMed     Text format    


  292. RAJA SK, Aggarwal S, Raman KR, Minteer WB, et al
    From businesswoman to banana vendor: mental health implications of HIV stigma in Tanzania.
    AIDS. 2016.
    PubMed     Text format    


  293. SCHRACK JA, Jacobson LP, Althoff KN, Erlandson KM, et al
    Effect of HIV-infection and cumulative viral load on age-related decline in grip strength.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  294. ASBJORNSDOTTIR KH, Hughes JP, Wamalwa D, Langat A, et al
    Differences in virologic and immunologic response to antiretroviral therapy among HIV-1 infected infants and children.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  295. LODI S, Sharma S, Lundgren JD, Phillips AN, et al
    The per-protocol effect of immediate vs. deferred ART initiation in the START randomized trial.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  296. TJIAM MC, Sariputra L, Armitage JD, Taylor JP, et al
    Control of early HIV-1 infection associates with plasmacytoid DC-reactive opsonophagocytic IgG antibodies to HIV-1 p24.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  297. BROWN LB, Havlir DV, Ayieko J, Mwangwa F, et al
    High levels of retention in care with streamlined care and universal test-and-treat in East Africa.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  298. VUILLE-LESSARD E, Lebouche B, Lennox L, Routy JP, et al
    nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV mono-infected patients.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  299. KELESIDIS T, Jackson N, McComsey GA, Wang X, et al
    Oxidized lipoproteins are associated with markers of inflammation andimmune activation in HIV-1 infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  300. VILLABONA-ARENAS CJ, Vidal N, Guichet E, Serrano L, et al
    In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    August 2016
  301. GUPTA SK, Dube MP, Stein JH, Clauss MA, et al
    A pilot trial of pentoxifylline on endothelial function and inflammation in HIV-infected patients initiating antiretroviral therapy.
    AIDS. 2016;30:2139-42.
    PubMed     Text format    


  302. MILLARD JD, Henry J, Rizvi SS, Nelson M, et al
    Direct-acting antivirals for acute hepatitis C in HIV-infected MSM.
    AIDS. 2016;30:2137-9.
    PubMed     Text format    


  303. DENNEMAN L, Cohen S, Godfried MH, van Leeuwen E, et al
    In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants.
    AIDS. 2016;30:2135-7.
    PubMed     Text format    


  304. BRADLEY H, Mattson CL, Beer L, Huang P, et al
    Increased antiretroviral therapy prescription and HIV viral suppression among persons receiving clinical care for HIV infection.
    AIDS. 2016;30:2117-24.
    PubMed     Text format     Abstract available


  305. MULANOVICH VE, Desai PA, Popat UR
    Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies: report of 5 cases after 2010.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  306. ALVAREZ H, Marino A, Garcia-Rodriguez JF, Vilas-Sueiro A, et al
    Immune reconstitution inflammatory syndrome in an HIV-infected patient using subcutaneous silicone fillers.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  307. WAGNER GA, Chaillon A, Liu S, Franklin DR Jr, et al
    HIV-associated neurocognitive disorder is associated with HIV-1 dual infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  308. SMITH JA, Daniel R
    Human vaginal fluid contains exosomes that have an inhibitory effect on an early step of the HIV-1 life cycle.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  309. KUNKEL A, Crawford FW, Shepherd J, Cohen T, et al
    Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining TB/HIV co-epidemic.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  310. MOSEHOLM E, Helleberg M, Nordly SB, Rosenfeldt V, et al
    Hospital admission among HIV-exposed uninfected children compared to HIV-unexposed children - a nationwide cohort study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  311. TCHOUNGA BK, Hnge BL, Eholie SP, Coffie PA, et al
    Effect of sex and age on outcomes among hiv-2 infected patients starting antiretroviral therapy in west africa: a multicentre cohort study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  312. HIRA S, Piot P
    The counter effects of the ebola epidemic on control and treatment of HIV/AIDS, tuberculosis, and malaria in West Africa.
    AIDS. 2016.
    PubMed     Text format    


  313. BUGGERT M, Frederiksen J, Lund O, Betts MR, et al
    CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  314. EMMER KL, Wieczorek L, Tuyishime S, Molnar S, et al
    Antibody responses to prime-boost vaccination with an HIV-1 gp145 Env protein and chimpanzee adenovirus vectors expressing HIV-1 gp140.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  315. KIM AA, Mukui I, Young PW, Mirjahangir J, et al
    Undisclosed HIV infection and art use in the kenya AIDS indicator survey 2012: relevance to targets for HIV diagnosis and treatment in kenya.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  316. POLIS CB, Phillips SJ, Hillier SL, Achilles SL, et al
    Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?
    AIDS. 2016.
    PubMed     Text format    


  317. POLIS CB, Curtis KM, Hannaford PC, Phillips SJ, et al
    Update on hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence, 2016.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  318. GILL AL, Green SA, Abdullah S, Le Saout C, et al
    PD1/PD-L1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-PD-L1 (Avelumab).
    AIDS. 2016.
    PubMed     Text format     Abstract available


  319. ESCUDERO DJ, Lurie MN, Mayer KH, Weinreb C, et al
    Acute HIV infection transmission among people who inject drugs in a mature epidemic setting.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  320. OLIVER NT, Hartman CM, Kramer JR, Chiao EY, et al
    Statin drugs decrease progression to cirrhosis in HIV/HCV co-infected individuals.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  321. THOMAS GP, Li X, Post WS, Jacobson LP, et al
    Associations between antiretroviral use and subclinical coronary atherosclerosis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  322. GOWDA C, Brown TT, Compher C, Forde KA, et al
    Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  323. KRUBINER CB, Faden RR, Cadigan RJ, Gilbert SZ, et al
    Advancing HIV research with pregnant women: navigating challenges and opportunities.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    July 2016

  324. Long-term impact of HIV wasting on physical function: Erratum.
    AIDS. 2016;30:2007.
    PubMed     Text format    



  325. Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection: Erratum.
    AIDS. 2016;30:2005.
    PubMed     Text format    


  326. CACHAY E, Soriano V
    Is HIV still a special population for the treatment of hepatitis C?
    AIDS. 2016;30:2001-3.
    PubMed     Text format    


  327. SCHALKWIJK S, Feiterna-Sperling C, Weizsacker K, Colbers A, et al
    Substantially lowered dolutegravir exposure in a treatment-experienced perinatally HIV-1-infected pregnant woman.
    AIDS. 2016;30:1999-2001.
    PubMed     Text format    


  328. CHIODI F
    Pneumococcal vaccination of HIV-infected young adults is an important global priority.
    AIDS. 2016;30:1991-3.
    PubMed     Text format    


  329. FRIEDMAN EE, Duffus WA
    Chronic health conditions in medicare beneficiaries 65 years and older with HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  330. MATEY EJ, Tokoro M, Mizuno T, Matsumura T, et al
    Positive correlation of HIV infection with Giardia intestinalis assemblage B but not with assemblage A in asymptomatic Kenyan children.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  331. BAUTISTA-ARREDONDO S, Sosa-Rubi SG, Opuni M, Contreras-Loya D, et al
    Costs along the HTC and PMTCT service cascades: findings from Kenya, Rwanda, South Africa, and Zambia.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  332. BRENNAN AT, Bonawitz R, Gill CJ, Thea D, et al
    A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared to HIV-unexposed uninfected infants and children.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  333. SHAHMANESH M, Schultze A, Burns F, Kirk O, et al
    The cardiovascular risk management for people living with HIV in Europe: how well are we doing?
    AIDS. 2016.
    PubMed     Text format     Abstract available


  334. STOHR W, Dunn DT, Arenas-Pinto A, Orkin C, et al
    Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy in the PIVOT trial.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  335. KASSANJEE R, Pilcher CD, Busch MP, Murphy G, et al
    Viral load criteria and threshold optimization to improve HIV incidence assay characteristics - a CEPHIA analysis.
    AIDS. 2016.
    PubMed     Text format     Abstract available



  336. HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls: Erratum.
    AIDS. 2016;30:1863.
    PubMed     Text format    



  337. Assessing efficacy of a retention in care intervention among HIV patients with depression, anxiety, heavy alcohol consumption and illicit drug use: Erratum.
    AIDS. 2016;30:1861.
    PubMed     Text format    


  338. ROKX C, Vella S, Pantaleo G, Levy Y, et al
    Unite forces to validate biomarkers in the quest for lasting HIV remission.
    AIDS. 2016;30:1859-60.
    PubMed     Text format    


  339. DES JARLAIS DC, Carrieri P
    HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks: authors' reply.
    AIDS. 2016;30:1858-9.
    PubMed     Text format    


  340. CAZEIN F, Pillonel J, Barin F, Jauffret-Roustide M, et al
    HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks.
    AIDS. 2016;30:1857-8.
    PubMed     Text format    


  341. BOYD A, Lacombe K, Girard PM
    An improved understanding of severe liver morbidity in HIV-infected individuals.
    AIDS. 2016;30:1843-5.
    PubMed     Text format    


  342. AHMAD A, Mehraj V, Jenabian MA, Samarani S, et al
    Combination antiretroviral therapy and indoleamine 2,3-dioxygenase in HIV infections: challenges and new opportunities.
    AIDS. 2016;30:1839-41.
    PubMed     Text format    


  343. YEK C, Gianella S, Plana M, Castro P, et al
    Standard vaccines increase HIV-1 transcription during antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  344. ARPADI SM, Shiau S, Strehlau R, Patel F, et al
    Efavirenz is associated with higher bone mass in South African children with HIV.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  345. PARK SY, Mack WJ, Lee HY
    Enhancement of viral escape in HIV-1 Nef by STEP vaccination.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  346. CHEW KW, Bhattacharya D
    Virologic and immunologic aspects of HIV-HCV coinfection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  347. EVANS C, Chasekwa B, Ntozini R, Humphrey JH, et al
    Head circumferences of children born to HIV-infected and HIV-uninfected mothers in Zimbabwe during the pre-ART era.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  348. VOSS JE, Macauley MS, Rogers KA, Villinger F, et al
    Reproducing SIVDeltanef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front lines.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  349. SAMRI A, Bacchus-Souffan C, Hocqueloux L, Avettand-Fenoel V, et al
    Polyfunctional HIV-specific T-cells in post-treatment controllers.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  350. DE MONTEYNARD LA, Matheron S, Gilquin J, Pavie J, et al
    Influence of geographic origin, sex and HIV transmission group on the outcome of first-line combined antiretroviral therapy (cART) in France.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    June 2016
  351. OLIVEIRA M, Ibanescu RI, Pham HT, Brenner B, et al
    The M184I/V and K65R nucleoside resistance mutations in HIV-1 prevent the emergence of resistance mutations against dolutegravir.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  352. HONTELEZ JA, Chang AY, Ogbuoji O, Vlas SJ, et al
    Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: Investment needs, population health gains, and cost-effectiveness.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  353. HARPER K
    The emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland.
    AIDS. 2016.
    PubMed     Text format    


  354. ROBERTSON KR, Miyahara S, Lee A, Brown TT, et al
    Neurocognition in maraviroc- compared to tenofovir: a double blind randomized placebo controlled trial ACTG A5303.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  355. DUARTE F, Miranda AC, Peres S, Diogo I, et al
    Transmitted drug resistance in drug-naive HIV-2 infected patients.
    AIDS. 2016;30:1687-8.
    PubMed     Text format    


  356. GERVASONI C, Minisci D, Meraviglia P, Baldelli S, et al
    Determinants of bone diseases in tenofovir-treated HIV patients.
    AIDS. 2016;30:1686-7.
    PubMed     Text format    


  357. HAGAN H, Jordan AE, Cleland CM
    Response to the calculation of population attributable fractions of risk factors for hepatitis C transmission: authors' reply.
    AIDS. 2016;30:1685.
    PubMed     Text format    


  358. MOOG C, Mayr L, Tolstrup M
    New insights on the phenotype of HIV reservoirs.
    AIDS. 2016;30:1675-6.
    PubMed     Text format    


  359. MAKUMBI FE, Ssempijja V, Sekasanvu J, Ssekubugu R, et al
    Postcoital penile washing and the risk of HIV acquisition in uncircumcised men.
    AIDS. 2016;30:1669-73.
    PubMed     Text format     Abstract available


  360. STERLING TR, Scott NA, Miro JM, Calvet G, et al
    Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.
    AIDS. 2016;30:1607-15.
    PubMed     Text format     Abstract available


  361. MOLDT B, Le KM, Carnathan DG, Whitney JB, et al
    Neutralizing antibody affords comparable protection against vaginal and rectal simian/human immunodeficiency virus challenge in macaques.
    AIDS. 2016;30:1543-51.
    PubMed     Text format     Abstract available


  362. KOJIMA N, Davey DJ, Klausner JD
    Pre-exposure prophylaxis for human immunodeficiency virus and sexually transmitted infection acquisition among men who have sex with men.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  363. LESKO CR, Edwards JK, Moore RD, Lau B, et al
    A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of injection drug use.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  364. FITCH KV, DeFilippi C, Christenson R, Srinivasa S, et al
    Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  365. DELVA W, Leventhal GE, Helleringer S
    Connecting the dots: network data and models in HIV epidemiology.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  366. AMU S, Fievez V, Nozza S, Lopalco L, et al
    Dysfunctions in the migratory phenotype and properties of circulating immature transitional B cells during HIV-1 Infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  367. YONG YK, Shankar EM, Solomon A, Spelman T, et al
    Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  368. GARCIA M, Le Moal G, Godet C, Beraud G, et al
    First case report of renal improvement on tenofovir alafenamide in an HIV/hepatitis B virus-coinfected patient with adefovir-induced Fanconi's syndrome.
    AIDS. 2016;30:1487-8.
    PubMed     Text format    


  369. KADEDE K, Ruel T, Kabami J, Ssemmondo E, et al
    Increased adolescent HIV testing with a hybrid mobile strategy in Uganda and Kenya.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  370. MUMMERT C, Hofmann C, Huckelhoven AG, Bergmann S, et al
    T-cell receptor transfer for boosting HIV-1-specific T-cell immunity in HIV-1-infected patients.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  371. VAN DEN KERKHOF TL, van Gils MJ, Boeser-Nunnink BD, Burger JA, et al
    Probability of N332 glycan occupancy on HIV-1 gp120 modulates sensitivity to broadly neutralizing antibodies.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  372. FERGUSON D, Clarke S, Berry N, Almond N, et al
    Attenuated SIV causes persisting neuroinflammation in the absence of a chronic viral load and neurotoxic ART.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    May 2016
  373. GIROMETTI N, Jones R, Levy J, McCormack S, et al
    Risks and benefits of HIV pre exposure prophylaxis with tenofovir/emtricitabine in an older man with co-morbidities.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  374. JIN C, Peng X, Liu F, Cheng L, et al
    Interferon-induced SAMHD1 expression in astrocytes and microglia is mediated by miR-181a.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  375. KAGAAYI J, Kong X, Kigozi G, Ssekubugu R, et al
    Self-selection of male circumcision clients and behaviors following circumcision in a service program in rakai, Uganda.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  376. LONGENECKER CT, Sattar A, Gilkeson R, Mccomsey GA, et al
    Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  377. MONROE AK, Haberlen SA, Post WS, Palella FJ Jr, et al
    Cardiovascular disease risk scores' relationship to subclinical cardiovascular disease among HIV-infected and-uninfected men.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  378. AKGUN KM, Tate JP, Oursler KK, Crystal S, et al
    Association of chronic obstructive pulmonary disease (COPD) with frailty measurements in HIV-infected and uninfected Veterans.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  379. NGUYEN TP, Shukla S, Asaad R, Freeman ML, et al
    Responsiveness to IL-7 but not to IFN-alpha is diminished in CD4 T cells from treated HIV infected patients who experience poor CD4 T cell recovery.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  380. ASAHCHOP EL, Akinwumi SM, Branton WG, Fujiwara E, et al
    Plasma microRNA profiling predicts HIV-associated neurocognitive disorder.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  381. BREY FL, Seybold U, Kollan C, Bogner JR, et al
    Accelerated CD4 decline in untreated HIV-1 patients points toward increasing virulence over the course of the epidemic.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  382. KOZLOWSKI HN, Lai ET, Havugimana PC, White C, et al
    Extracellular histones identified in crocodile blood inhibit in vitro HIV-1 infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  383. WAMALWA D, Benki-Nugent S, Langat A, Tapia K, et al
    Treatment interruption after 2-year antiretroviral treatment (ART) initiated during acute/early HIV in infancy: a randomized trial.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  384. OKULICZ JF, Boufassa F, Costagliola D, Ganesan A, et al
    Cancers In Elite Controllers: Appropriate Follow-up is Essential.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  385. VASE MO, Ludvigsen M, Bendix K, Hamilton-Dutoit S, et al
    Proteomic profiling of pre-treatment serum from HIV infected patients identifies candidate markers predictive of lymphoma development.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  386. HSU DC, Ma YF, Hur S, Li D, et al
    Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive ART.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  387. CHEN P, Yi Z, Zhang W, Klotman ME, et al
    HIV infection-induced transcriptional program in renal tubular epithelial cells activates a CXCR2 driven CD4+ T cell chemotactic response.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  388. JASKIEWICZ W, Oketcho V, Settle D, Frymus D, et al
    Investing in the health workforce to increase access to and use of HIV and AIDS services in Uganda.
    AIDS. 2016.
    PubMed     Text format    


  389. ANGLEWICZ P, VanLandingham M, Manda-Taylor L, Kohler HP, et al
    Migration and HIV infection in malawi: A population-based longitudinal study.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  390. JEAN K, Puren A, Cutler E, Singh B, et al
    Level of Viral Suppression and the Cascade of HIV Care in a South-African Semi-urban Setting in 2012.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  391. CROWELL TA, Phanuphak N, Pinyakorn S, Kroon E, et al
    Virologic failure is uncommon after treatment initiation during acute HIV infection.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  392. BACHLE SM, Malone DF, Buggert M, Karlsson AC, et al
    Elevated levels of iNKT cell and NK cell activation correlate with disease progression in HIV-1 and HIV-2 infections.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    April 2016
  393. FIORE JR, Zoboli F, Di Stefano M, Faleo G, et al
    Impact of adding raltegravir to antiretroviral regimens in patients with blood viral suppression but persistent seminal viral shedding.
    AIDS. 2016;30:1144-6.
    PubMed     Text format    


  394. ALVAREZ-ROMAN MT, Rivas Pollmar MI, Bernardino JI, Lozano ML, et al
    Thrombopoietin receptor agonists in conjunction with oseltamivir for immune thrombocytopenia.
    AIDS. 2016;30:1141-2.
    PubMed     Text format    


    January 2016
  395. JANI IV, Quevedo JI, Tobaiwa O, Bollinger T, et al
    Use of mobile phone technology to improve the quality of point-of-care testing in a low-resource setting.
    AIDS. 2016;30:159-61.
    PubMed     Text format    


  396. MOOIJ SH, van Santen DK, Geskus RB, van der Sande MA, et al
    The effect of HIV infection on anal and penile human papillomavirus incidence and clearance: a cohort study among MSM.
    AIDS. 2016;30:121-32.
    PubMed     Text format     Abstract available


  397. OLSTHOORN AV, Sivachandran N, Bogoch I, Kwantampora J, et al
    Barriers to the uptake of postexposure prophylaxis among Nairobi-based female sex workers.
    AIDS. 2016;30:99-103.
    PubMed     Text format     Abstract available


  398. COGHILL AE, Shiels MS, Rycroft RK, Copeland G, et al
    Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer?
    AIDS. 2016;30:105-12.
    PubMed     Text format     Abstract available


  399. SCHURMANN D, Sobotha C, Gilmartin J, Robberechts M, et al
    A randomized, double-blind, placebo-controlled, short-term monotherapy study of doravirine in treatment-naive HIV-infected individuals.
    AIDS. 2016;30:57-63.
    PubMed     Text format     Abstract available


  400. SAVAGE EJ, Lowndes CM, Sullivan AK, Back DJ, et al
    Effect of nondisclosure of HIV status in sexual health clinics on unlinked anonymous HIV prevalence estimates in England, 2005-2009.
    AIDS. 2016;30:145-9.
    PubMed     Text format     Abstract available


  401. CHOW FC, Boscardin WJ, Mills C, Ko N, et al
    Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals.
    AIDS. 2016;30:45-55.
    PubMed     Text format     Abstract available


  402. GESKUS RB, Gonzalez C, Torres M, Del Romero J, et al
    Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors.
    AIDS. 2016;30:37-44.
    PubMed     Text format     Abstract available


    September 2015
  403. KOETHE JR, Grome H, Jenkins CA, Kalams SA, et al
    The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy.
    AIDS. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: